NASDAQ: ENGNEngene Therapeutics Inc Stock Ownership - Who owns Engene Therapeutics?
Insider buying vs selling
Have Engene Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ENGN insiders and whales buy or sell their stock.
ENGN Shareholders
What type of owners hold Engene Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Forbion Growth Opportunities Fund I Cooperatief Ua | 10.14% | 6,798,362 | $12.24M | Insider |
| Lumira Capital Investment Management Inc | 5.74% | 3,849,299 | $6.93M | Insider |
| De Solidarite Des Travailleurs Du Quebec Fonds | 4.53% | 3,036,153 | $5.47M | Insider |
| Forbion Capital Fund III Cooperatief Ua | 4.32% | 2,894,735 | $5.21M | Insider |
| Growth Sponsor Feac I. Bv Forbion | 2.98% | 2,000,000 | $3.60M | Insider |
| Gerald A. Brunk | 0.23% | 152,974 | $275.35k | Insider |
| Bvf Partners L P | 0.16% | 104,257 | $187.66k | Insider |
| Anthony Tzeyew Cheung | 0.15% | 102,873 | $185.17k | Insider |
| Richard M. Glickman | 0.04% | 24,675 | $44.42k | Insider |
| Philip Astleysparke | 0.03% | 20,000 | $36.00k | Insider |
ENGN vs Biotech Stocks
Engene Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.